Literature DB >> 16133421

Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.

Ivan Tancevski1, Sasa Frank, Petra Massoner, Ursula Stanzl, Wilfried Schgoer, Andreas Wehinger, Catherine Fievet, Philipp Eller, Josef R Patsch, Andreas Ritsch.   

Abstract

Scavenger receptor class B type I (SR-BI), a CD36 family member, plays a key role in high-density lipoprotein (HDL) metabolism, reverse cholesterol transport, and whole body cholesterol homeostasis, and is shown to be involved in the development of atherosclerosis in mice. In this report, we describe the effects of the adenoviral overexpression of human SR-BI (hSR-BI) in New Zealand White (NZW) rabbits, a wild-type animal model that expresses cholesteryl ester transfer protein (CETP) in plasma, displays a manlike lipoprotein profile, and is susceptible to atherosclerosis. A total of 1x10(12) adenoviral particles containing either hSR-BI or lacZ complementary deoxyribonucleic acid (control) were infused into the ear vein of NZW rabbits. Transgene expression was ascertained by TaqMan Real Time polymerase chain reaction measurements. Rabbits infected with Ad/hSR-BI (adenoviral plasmids containing hSR-BI) showed a faster clearance of administered [3H]HDL cholesterol and significantly decreased apolipoprotein (apo) A-I levels when compared to control rabbits, respectively. Interestingly, we found markedly increased levels of low-density lipoprotein (LDL) cholesterol exclusively in SR-BI-overexpressing rabbits. These changes were not accompanied by alterations in LDL receptor expression but by increased levels of CE transfer in these animals. By lowering HDL cholesterol and increasing plasma apoB-containing lipoprotein levels, the overexpression of SR-BI leads to a lipoprotein pattern, which is believed to enhance the development of atherosclerosis. The role of SR-BI in lipoprotein metabolism and atherogenesis in rabbits--a CETP-expressing animal model displaying a manlike lipoprotein profile--may therefore be different from the one found in rodents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133421     DOI: 10.1007/s00109-005-0695-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  22 in total

1.  An improved anion-exchange HPLC method for the detection and purification of adenoviral particles.

Authors:  F Blanche; B Cameron; A Barbot; L Ferrero; T Guillemin; S Guyot; S Somarriba; D Bisch
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor.

Authors:  S L Acton; P E Scherer; H F Lodish; M Krieger
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

3.  Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1.

Authors:  G Lambert; M B Chase; K Dugi; A Bensadoun; H B Brewer; S Santamarina-Fojo
Journal:  J Lipid Res       Date:  1999-07       Impact factor: 5.922

4.  Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E.

Authors:  D Goti; A Hrzenjak; S Levak-Frank; S Frank; D R van der Westhuyzen; E Malle; W Sattler
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.

Authors:  S Acton; A Rigotti; K T Landschulz; S Xu; H H Hobbs; M Krieger
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

6.  Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.

Authors:  B Trigatti; H Rayburn; M Viñals; A Braun; H Miettinen; M Penman; M Hertz; M Schrenzel; L Amigo; A Rigotti; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

7.  Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1.

Authors:  G Cao; C K Garcia; K L Wyne; R A Schultz; K L Parker; H H Hobbs
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

8.  Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family.

Authors:  D Calvo; M A Vega
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

9.  Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.

Authors:  N Wang; T Arai; Y Ji; F Rinninger; A R Tall
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

10.  Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency.

Authors:  S Kaser; A Sandhofer; B Hölzl; R Gander; C F Ebenbichler; B Paulweber; J R Patsch
Journal:  J Intern Med       Date:  2003-02       Impact factor: 8.989

View more
  10 in total

1.  The thyromimetic T-0681 protects from atherosclerosis.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Julia Hoefer; Philipp Eller; Eva Huber; Ursula Stanzl; Kristina Duwensee; Kristina Auer; Wilfried Schgoer; Volker Kuhn; Catherine Fievet; Frans Stellaard; Mats Rudling; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

2.  Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Huber; Kathrin Hochegger; Wilfried Schgoer; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

Review 3.  The resurgence of thyromimetics as lipid-modifying agents.

Authors:  Ivan Tancevski; Philipp Eller; Josef R Patsch; Andreas Ritsch
Journal:  Curr Opin Investig Drugs       Date:  2009-09

4.  Influence of aspirin on SR-BI expression in human carotid plaques.

Authors:  Andreas Wehinger; Ivan Tancevski; Ruediger Seiler; Sandra M Frotschnig; Stefan Frantz; Julia Huber; Philipp Eller; Wilfried Schgoer; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
Journal:  Atherosclerosis       Date:  2009-02-03       Impact factor: 5.162

5.  Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.

Authors:  Egon Demetz; Ivan Tancevski; Kristina Duwensee; Ursula Stanzl; Eva Huber; Christiane Heim; Florian Handle; Markus Theurl; Andrea Schroll; Anne Tailleux; Hermann Dietrich; Josef R Patsch; Philipp Eller; Andreas Ritsch
Journal:  Atherosclerosis       Date:  2012-03-23       Impact factor: 5.162

6.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

7.  Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.

Authors:  Kristina Duwensee; Stefan Schwaiger; Ivan Tancevski; Kathrin Eller; Miranda van Eck; Patrick Markt; Tobias Linder; Ursula Stanzl; Andreas Ritsch; Josef R Patsch; Daniela Schuster; Hermann Stuppner; David Bernhard; Philipp Eller
Journal:  Atherosclerosis       Date:  2011-07-21       Impact factor: 5.162

8.  Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter.

Authors:  Katsuyuki Hamada; Toshiro Shirakawa; Shuji Terao; Akinobu Gotoh; Kenzaburo Tani; Wenlin Huang
Journal:  Mol Ther Methods Clin Dev       Date:  2014-05-28       Impact factor: 6.698

Review 9.  Scavenger receptor structure and function in health and disease.

Authors:  Izma Abdul Zani; Sam L Stephen; Nadeem A Mughal; David Russell; Shervanthi Homer-Vanniasinkam; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Cells       Date:  2015-05-22       Impact factor: 6.600

10.  The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.

Authors:  Ivan Tancevski; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Hoefer; Christiane Heim; Ursula Stanzl; Andreas Wehinger; Kristina Auer; Regina Karer; Julia Huber; Wilfried Schgoer; Miranda Van Eck; Jonathan Vanhoutte; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.